Boston Scientific's total assets for Q2 2025 were $41.56B, an increase of 3.54% from the previous quarter. GB:0HOY total liabilities were $18.91B for the fiscal quarter, a 6.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.